Showing results (1-10 of 9) with videos related to
Sort By:
Pageof 1
Experimental Neurology|November 26, 2003
Neuroprotective actions of the ginseng extract G115 in two rodent models of Parkinson's diseaseJackalina Van Kampen, Harold Robertson, Theo Hagg, et al.Magnetic Resonance Imaging|September 21, 2010
Diffusion tensor fiber tractography of the olfactory tractMikael Skorpil, Tyler Rolheiser, Harold Robertson, et al.Progress in Neuro-Psychopharmacology & Biological Psychiatry|November 24, 2005
Effects of clozapine plus lamotrigine on phencyclidine-induced hyperactivityHarriet J Williams, Christina R Zamzow, Harold Robertson, et al.Journal of Neurology|August 28, 2009
Lack of functional relevance of isolated cell damage in transplants of Parkinson's disease patientsOliver Cooper, Arnar Astradsson, Penny Hallett, et al.Journal of Ocular Pharmacology and Therapeutics : the Official Journal of the Association for Ocular Pharmacology and Therapeutics|July 21, 2011
Nonpsychotropic cannabinoids, abnormal cannabidiol and canabigerol-dimethyl heptyl, act at novel cannabinoid receptors to reduce intraocular pressureAnna-Maria Szczesniak, Yehoshua Maor, Harold Robertson, et al.Cell Reports|June 10, 2014
Long-term health of dopaminergic neuron transplants in Parkinson's disease patientsPenelope J Hallett, Oliver Cooper, Damaso Sadi, et al.Journal of Neurosurgery|March 9, 2002
Simultaneous intrastriatal and intranigral fetal dopaminergic grafts in patients with Parkinson disease: a pilot study. Report of three casesIvar Mendez, Alain Dagher, Murray Hong, et al.Nature Medicine|April 9, 2008
Dopamine neurons implanted into people with Parkinson's disease survive without pathology for 14 yearsIvar Mendez, Angel Viñuela, Arnar Astradsson, et al.Clinical EEG and Neuroscience|November 29, 2021
Olfactory Function and Diffusion Tensor Imaging as Markers of Mild Cognitive Impairment in Early Stages of Parkinson's DiseaseSophie A Stewart, Laura Pimer, John D Fisk, et al.Pageof 1